GAWK (chromogranin-B 420-493) is a 74 amino acid peptide recently isolated from human pituitaries. Using two different antibodies (directed against GAWK [1-17] and [20-38] fragments) GAWK-LI was measured in tumors from 194 patients and in the plasma of 434 patients by RIA. The highest tissue concentrations of GAWK-LI were found in pheochromocytoma (GAWK [1-17]-LI, 18,173 +/- 3,915; GAWK [20-38]-LI, 17,852 +/- 2,763 [mean +/- SEM] pmol/g wet wt tissue; n = 9), which were at least ten times higher than any other tumors producing GAWK-LI. High concentrations of GAWK-LI were also found in other types of endocrine tumors including carcinoid, medullary carcinoma of thyroid, pancreatic, and ACTH-producing lung tumors. On the other hand, low concentrations of GAWK-LI were found in nonendocrine tumors. Plasma concentrations of GAWK-LI were found to be elevated in patients with endocrine tumor, but more so in those with pancreatic tumors than with pheochromocytomas. Plasma concentrations returned to normal after successful tumor removal. Chromatographic profiles of GAWK-LI in extracts of pheochromocytomas and normal adrenals showed high molecular weight peaks that were absent in the extracts of other endocrine tumors and normal pancreas, suggesting differential tissue-specific processing. Thus GAWK-LI is produced by a variety of endocrine tumors and may serve as a plasma tumor marker, especially in patients with pancreatic endocrine tumors.
K Sekiya, M A Ghatei, M J Salahuddin, A E Bishop, Q A Hamid, H Ibayashi, J M Polak, S R Bloom
Title and authors | Publication | Year |
---|---|---|
Поиск новых иммуногистохимических и циркулирующих маркеров инсулиномы
Юкина МЮ, Трошина ЕА, Урусова ЛС, Нуралиева НФ, Никанкина ЛВ, Иоутси ВА, Реброва ОЮ, Мокрышева НГ |
Problems of Endocrinology | 2024 |
Role of biomarker tests for diagnosis of neuroendocrine tumours
J Hofland, WT Zandee, WW de Herder |
Nature Reviews Endocrinology | 2018 |
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours
PJ Monaghan, A Lamarca, JW Valle, RA Hubner, W Mansoor, PJ Trainer, D Darby |
Clinical Endocrinology | 2015 |
Characterization and Plasma Measurement of the WE-14 Peptide in Patients with Pheochromocytoma
J Guillemot, M Guérin, E Thouënnon, M Montéro-Hadjadje, J Leprince, H Lefebvre, M Klein, M Muresan, Y Anouar, L Yon, S Gasman |
PloS one | 2014 |
Mass spectrometry identification of granins and other proteins secreted by neuroblastoma cells
W Rozek, M Kwasnik, J Debski, JF Zmudzinski |
Tumor Biology | 2013 |
The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study
R Dobson, MI Burgess, M Banks, DM Pritchard, J Vora, JW Valle, C Wong, C Chadwick, K George, B Keevil, J Adaway, JE Ardill, A Anthoney, U Hofmann, GJ Poston, DJ Cuthbertson, P Holvoet |
PloS one | 2013 |
The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia
Bech, NM Martin, R Ramachandran, |
Annals of Clinical Biochemistry | 2013 |
The Pituitary
X Bertagna, L Guignat, MC Raux-Demay, B Guilhaume, F Girard |
The Pituitary | 2011 |
Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma
M Guérin, J Guillemot, E Thouënnon, A Pierre, FZ El-Yamani, M Montero-Hadjadje, C Dubessy, R Magoul, I Lihrmann, Y Anouar, L Yon |
Regulatory Peptides | 2010 |
Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors
JM Conlon |
Regulatory Peptides | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy
P Bech, V Winstanley, KG Murphy, AH Sam, K Meeran, MA Ghatei, SR Bloom |
The Journal of clinical endocrinology and metabolism | 2008 |
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis
N Mattsson, U Rüetschi, VN Podust, M Stridsberg, S Li, O Andersen, S Haghighi, K Blennow, H Zetterberg |
Journal of Neurochemistry | 2007 |
Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma
J Guillemot, Y Anouar, M Montero-Hadjadje, E Grouzmann, L Grumolato, J Roshmaninho-Salgado, V Turquier, C Duparc, H Lefebvre, PF Plouin, M Klein, M Muresan, BK Chow, H Vaudry, L Yon |
International Journal of Cancer | 2006 |
Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant Advances
RR Warner |
Gastroenterology | 2005 |
The Chromogranin–Secretogranin Family
L Taupenot, KL Harper, DT O'Connor |
New England Journal of Medicine | 2003 |
Chromogranin A: its clinical value as marker of neuroendocrine tumours
Nobels, Kwekkeboom, Bouillon, Lamberts |
European Journal of Clinical Investigation | 1998 |
Argyrophilia and chromogranin A and B immunostaining in patients with sporadic medullary thyroid carcinoma. a critical appraisal of their prognostic utility
L Scopsi, G Sampietro, P Boracchi, P Collini |
The Journal of Pathology | 1998 |
Identification of a new chromogranin B fragment (314–365) in endocrine tumors
MC Woussen-Colle, P Gourlet, A Vandermeers, MC Vandermeers-Piret, J D'Haens, B Velkeniers, P Robberechi |
Peptides | 1995 |
Posttranslational processing of proenkephalins and chromogranins/secretogranins
L Dillen, B Miserez, M Claeys, D Aunis, WD Potter |
Neurochemistry International | 1993 |
Differential regulation of chromogranin B/secretogranin I and secretogranin II by forskolin in PC12 cells
ME Thompson, WE Zimmer, LB Wear, LA MacMillan, WJ Thompson, WB Huttner, H Hidaka, JG Scammell |
Molecular Brain Research | 1992 |
The chromogranins A and B: The first 25 years and future perspectives
H Winkler, R Fischer-Colbrie |
Neuroscience | 1992 |
Production of chromogranin A and B derived peptides in human small cell lung carcinoma cell lines
H Iguchi, S Bannai, N Takanashi, Y Tsukada |
European Journal of Cancer | 1992 |
Pulmonary Endocrine Pathology
JR Gosney |
Pulmonary Endocrine Pathology | 1992 |
Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumors of the lung
M Tötsch, LC Müller, A Hittmair, D Öfner, AR Gibbs, KW Schmid |
Human Pathology | 1992 |
Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study
KW Schmid, A Hittmair, D Ladurner, P Sandbichler, R Gasser, M Tötsch |
Virchows Archiv A Pathological Anatomy and Histopathology | 1991 |
Gut endocrine and neural peptides
AE Bishop, JM Polak |
Endocrine Pathology | 1990 |
Cushing's disease
EJ Carry, I Walzer |
The American Journal of Surgery | 1960 |